Showing results (181-190 of 294) with videos related to

Sort By:
Pageof 30
BMC Biology|November 11, 2017
A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53Jin Huei Wong, Mohammad Alfatah, Mei Fang Sin, et al.
Oncotarget|February 15, 2011
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapyBhavya Rao, Ingeborg M M van Leeuwen, Maureen Higgins, et al.
Oncogene|February 13, 2018
p53 isoforms regulate premature aging in human cellsNatalia von Muhlinen, Izumi Horikawa, Fatima Alam, et al.
Cancer Research|April 15, 2024
Pushing the Frontiers of Cancer Research: Highlights from the Frontiers in Cancer Science Conference 2023Yi Fei Lee, Leilei Chen, Valerie Chew, et al.
Nanomaterials (Basel, Switzerland)|April 25, 2020
Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized LipodisksSara Lundsten, Víctor Agmo Hernández, Lars Gedda, et al.
Scientific Reports|December 17, 2013
Rational optimization of conformational effects induced by hydrocarbon staples in peptides and their binding interfacesDilraj Lama, Soo T Quah, Chandra S Verma, et al.
Cell Cycle (Georgetown, Tex.)|May 12, 2011
NPMc(+) AML cell line shows differential protein expression and lower sensitivity to DNA-damaging and p53-inducing anticancer compoundsQiao Jing Lew, Chuan Hao Tan, Meera Gurumurthy, et al.
Genome Research|July 26, 2017
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumorsMi Ni Huang, Willie Yu, Wei Wei Teoh, et al.
Cancer Research|August 1, 2025
Charting New Paths in Cancer Research: Insights from the Frontiers in Cancer Science Conference 2024Giang Le Minh, Sasidharan Swarnalatha Lucky, Shazib Pervaiz, et al.
Cancer Research|July 2, 2026
Forging New Pathways in Oncology: Strategic Insights from the 17th Annual Frontiers in Cancer Science ConferenceDachuan Huang, Wee Wei Tee, Sanjay De Mel, et al.
Pageof 30